I-Mab Biopharma
IMAB
#9310
Rank
NZ$0.11 B
Marketcap
$1.36
Share price
-5.65%
Change (1 day)
-55.22%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): NZ$5.17 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is NZ$5.47 Million. a decrease over the revenue in the year 2023 that were of NZ$0.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 NZ$0.14 M-139.76%
2022-NZ$0.38 Million-110.38%
2021NZ$3.62 M-94.01%
2020 NZ$60.52 M5798.4%
2019 NZ$1.02 M-46.01%
2018 NZ$1.9 M317.83%
2017NZ$0.45 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$0.37 M-93.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.19 B 21,690.08%๐Ÿ‡บ๐Ÿ‡ธ USA